LU81895A1 - Nouveaux derives de la perhydrothiazine-1,3, leur preparattion et les medicaments qui les contiennent - Google Patents
Nouveaux derives de la perhydrothiazine-1,3, leur preparattion et les medicaments qui les contiennent Download PDFInfo
- Publication number
- LU81895A1 LU81895A1 LU81895A LU81895A LU81895A1 LU 81895 A1 LU81895 A1 LU 81895A1 LU 81895 A LU81895 A LU 81895A LU 81895 A LU81895 A LU 81895A LU 81895 A1 LU81895 A1 LU 81895A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- general formula
- dithiocarbamate
- perhydrothiazine
- pyridyl
- product
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title description 4
- 229940126601 medicinal product Drugs 0.000 title description 2
- -1 alkyl radical Chemical class 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 15
- 239000012990 dithiocarbamate Substances 0.000 claims description 13
- 239000003814 drug Substances 0.000 claims description 9
- 125000005843 halogen group Chemical group 0.000 claims description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 7
- DKVNPHBNOWQYFE-UHFFFAOYSA-N carbamodithioic acid Chemical compound NC(S)=S DKVNPHBNOWQYFE-UHFFFAOYSA-N 0.000 claims description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 claims description 4
- 239000003085 diluting agent Substances 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 239000002671 adjuvant Substances 0.000 claims description 3
- 125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 claims description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 2
- 229920002554 vinyl polymer Polymers 0.000 claims description 2
- 229910052736 halogen Chemical group 0.000 claims 2
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 75
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 46
- 239000000047 product Substances 0.000 description 39
- 239000000203 mixture Substances 0.000 description 34
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 33
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 30
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 23
- 239000000243 solution Substances 0.000 description 22
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 16
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 13
- 229910052753 mercury Inorganic materials 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 239000000377 silicon dioxide Substances 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 11
- 239000012153 distilled water Substances 0.000 description 10
- 238000002844 melting Methods 0.000 description 10
- 230000008018 melting Effects 0.000 description 10
- 239000000725 suspension Substances 0.000 description 10
- 235000019271 petrolatum Nutrition 0.000 description 8
- 238000001953 recrystallisation Methods 0.000 description 8
- 239000013078 crystal Substances 0.000 description 7
- 238000001914 filtration Methods 0.000 description 7
- 238000002329 infrared spectrum Methods 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 6
- QPHMMPRFMVERHL-UHFFFAOYSA-N carbamodithioic acid;n,n-diethylethanamine Chemical compound NC([S-])=S.CC[NH+](CC)CC QPHMMPRFMVERHL-UHFFFAOYSA-N 0.000 description 6
- 229910052938 sodium sulfate Inorganic materials 0.000 description 6
- 235000011152 sodium sulphate Nutrition 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-O triethylammonium ion Chemical compound CC[NH+](CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-O 0.000 description 6
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- HGINCPLSRVDWNT-UHFFFAOYSA-N Acrolein Chemical compound C=CC=O HGINCPLSRVDWNT-UHFFFAOYSA-N 0.000 description 4
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 4
- 241000244206 Nematoda Species 0.000 description 4
- WZQDRRLBAPWQMS-UHFFFAOYSA-N pyridin-2-ylcarbamodithioic acid Chemical compound SC(=S)NC1=CC=CC=N1 WZQDRRLBAPWQMS-UHFFFAOYSA-N 0.000 description 4
- QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 201000006353 Filariasis Diseases 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- ICSNLGPSRYBMBD-UHFFFAOYSA-N 2-aminopyridine Chemical compound NC1=CC=CC=N1 ICSNLGPSRYBMBD-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 230000000507 anthelmentic effect Effects 0.000 description 2
- 229940124339 anthelmintic agent Drugs 0.000 description 2
- 239000000921 anthelmintic agent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000003701 inert diluent Substances 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- YWAKXRMUMFPDSH-UHFFFAOYSA-N pentene Chemical compound CCCC=C YWAKXRMUMFPDSH-UHFFFAOYSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- QRYAEUULRGDETI-UHFFFAOYSA-M (4,4-dimethyl-3-oxopentyl)-trimethylazanium;iodide Chemical compound [I-].CC(C)(C)C(=O)CC[N+](C)(C)C QRYAEUULRGDETI-UHFFFAOYSA-M 0.000 description 1
- 125000005999 2-bromoethyl group Chemical group 0.000 description 1
- PIJYPIKISHHMRB-UHFFFAOYSA-N 3-oxobutyl carbamodithioate Chemical compound C(N)(SCCC(C)=O)=S PIJYPIKISHHMRB-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241001465677 Ancylostomatoidea Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- TYYNJHRLNPGVET-UHFFFAOYSA-M C(N)([S-])=S.N1=C(C=CC=C1)[N+](CC)(CC)CC Chemical compound C(N)([S-])=S.N1=C(C=CC=C1)[N+](CC)(CC)CC TYYNJHRLNPGVET-UHFFFAOYSA-M 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 206010016675 Filariasis lymphatic Diseases 0.000 description 1
- 241000243780 Heligmosomoides polygyrus Species 0.000 description 1
- 208000006968 Helminthiasis Diseases 0.000 description 1
- 231100000111 LD50 Toxicity 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000243994 Litomosoides carinii Species 0.000 description 1
- 208000037263 Lymphatic filariasis Diseases 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 241000243985 Onchocerca volvulus Species 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000144290 Sigmodon hispidus Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 150000004659 dithiocarbamates Chemical class 0.000 description 1
- 208000008576 dracunculiasis Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 208000005239 filarial elephantiasis Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- VSHDHKDWBUMJIJ-UHFFFAOYSA-N iodo hypoiodite Chemical compound IOI VSHDHKDWBUMJIJ-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- WHQSYGRFZMUQGQ-UHFFFAOYSA-N n,n-dimethylformamide;hydrate Chemical compound O.CN(C)C=O WHQSYGRFZMUQGQ-UHFFFAOYSA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 208000002042 onchocerciasis Diseases 0.000 description 1
- 150000002895 organic esters Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 208000014837 parasitic helminthiasis infectious disease Diseases 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008174 sterile solution Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000003206 sterilizing agent Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 1
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7832387 | 1978-11-16 | ||
| FR7832387A FR2441626A1 (fr) | 1978-11-16 | 1978-11-16 | Nouveaux derives de la perhydrothiazine-1,3 leur preparation et les medicaments qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU81895A1 true LU81895A1 (fr) | 1980-06-05 |
Family
ID=9214965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU81895A LU81895A1 (fr) | 1978-11-16 | 1979-11-15 | Nouveaux derives de la perhydrothiazine-1,3, leur preparattion et les medicaments qui les contiennent |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US4271156A (de) |
| JP (1) | JPS5572187A (de) |
| AT (1) | ATA727679A (de) |
| AU (1) | AU5278479A (de) |
| BE (1) | BE880096A (de) |
| DE (1) | DE2946409A1 (de) |
| DK (1) | DK485179A (de) |
| ES (1) | ES485990A1 (de) |
| FR (1) | FR2441626A1 (de) |
| GB (1) | GB2037749A (de) |
| IL (1) | IL58728A0 (de) |
| IT (1) | IT1127241B (de) |
| LU (1) | LU81895A1 (de) |
| NL (1) | NL7908189A (de) |
| NZ (1) | NZ192119A (de) |
| OA (1) | OA06370A (de) |
| PH (1) | PH14654A (de) |
| PT (1) | PT70438A (de) |
| SE (1) | SE7909440L (de) |
| SU (1) | SU858565A3 (de) |
| ZA (1) | ZA796122B (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3780112T2 (de) * | 1986-04-10 | 1992-12-24 | Leo Pharm Prod Ltd | Verfahren zur herstellung von penicillansaeure-derivaten. |
| CN102234271B (zh) * | 2010-04-21 | 2015-06-10 | 北京大学 | 芳杂(烷基)氨基二硫代甲酸酯类化合物、其制备方法和应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2789114A (en) * | 1955-10-28 | 1957-04-16 | Dow Chemical Co | Triethylamine salt of nu-(2-pyridyl)-dithiocarbamic acid |
| US2909460A (en) * | 1957-03-21 | 1959-10-20 | Monsanto Chemicals | 3-amino-2, 3-dihydro-1, 3-thiazine-2-thiones and process of inhibiting fungus growth |
| US3726880A (en) * | 1971-09-07 | 1973-04-10 | Parke Davis & Co | Organic amides and methods for their production |
| US3732216A (en) * | 1971-11-17 | 1973-05-08 | Smith Kline French Lab | 3-heteroaryl-2-thio-1,3-thiazane-2,4-diones |
| NL7804977A (nl) * | 1977-05-17 | 1978-11-21 | Rhone Poulenc Ind | Nieuwe 4-hydroxythiazolidinethion-2-derivaten, de be- reiding ervan en preparaten, die de nieuwe derivaten bevatten. |
-
1978
- 1978-11-16 FR FR7832387A patent/FR2441626A1/fr active Pending
-
1979
- 1979-11-01 OA OA56930A patent/OA06370A/xx unknown
- 1979-11-08 NL NL7908189A patent/NL7908189A/nl not_active Application Discontinuation
- 1979-11-12 PT PT70438A patent/PT70438A/pt unknown
- 1979-11-14 ZA ZA00796122A patent/ZA796122B/xx unknown
- 1979-11-14 PH PH23279A patent/PH14654A/en unknown
- 1979-11-14 NZ NZ192119A patent/NZ192119A/xx unknown
- 1979-11-14 AU AU52784/79A patent/AU5278479A/en not_active Abandoned
- 1979-11-14 AT AT0727679A patent/ATA727679A/de unknown
- 1979-11-14 JP JP14663079A patent/JPS5572187A/ja active Pending
- 1979-11-14 GB GB7939432A patent/GB2037749A/en not_active Withdrawn
- 1979-11-14 US US06/094,335 patent/US4271156A/en not_active Expired - Lifetime
- 1979-11-15 IL IL58728A patent/IL58728A0/xx unknown
- 1979-11-15 DK DK485179A patent/DK485179A/da unknown
- 1979-11-15 SE SE7909440A patent/SE7909440L/xx unknown
- 1979-11-15 LU LU81895A patent/LU81895A1/fr unknown
- 1979-11-15 SU SU792841756A patent/SU858565A3/ru active
- 1979-11-15 ES ES485990A patent/ES485990A1/es not_active Expired
- 1979-11-16 DE DE19792946409 patent/DE2946409A1/de not_active Withdrawn
- 1979-11-16 IT IT27343/79A patent/IT1127241B/it active
- 1979-11-16 BE BE0/198160A patent/BE880096A/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5572187A (en) | 1980-05-30 |
| NL7908189A (nl) | 1980-05-20 |
| IT1127241B (it) | 1986-05-21 |
| OA06370A (fr) | 1981-08-31 |
| IT7927343A0 (it) | 1979-11-16 |
| US4271156A (en) | 1981-06-02 |
| GB2037749A (en) | 1980-07-16 |
| PH14654A (en) | 1981-10-14 |
| AU5278479A (en) | 1980-05-22 |
| NZ192119A (en) | 1981-12-15 |
| DK485179A (da) | 1980-05-17 |
| SU858565A3 (ru) | 1981-08-23 |
| FR2441626A1 (fr) | 1980-06-13 |
| BE880096A (fr) | 1980-05-16 |
| IL58728A0 (en) | 1980-02-29 |
| ES485990A1 (es) | 1980-05-16 |
| ATA727679A (de) | 1983-05-15 |
| ZA796122B (en) | 1980-11-26 |
| DE2946409A1 (de) | 1980-05-29 |
| PT70438A (fr) | 1979-12-01 |
| SE7909440L (sv) | 1980-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE851310A (fr) | Nouveaux derives de la tetrahydro-equinocandine b | |
| FR2511679A1 (fr) | Nouvelles imidazotetrazinones, leur preparation et les medicaments qui les contiennent | |
| FR2591596A1 (fr) | Nouvelles 4h-triazolo(4,3-a)(1,4)benzodiazepines, leur procede de preparation, leur application comme medicaments et les compositions les renfermant | |
| FR2667864A2 (fr) | Derives de n-phenyl glycinamides, leur preparation et les medicaments les contenant. | |
| FR2601015A1 (fr) | Nouveaux derives du 1h,3h-pyrrolo (1,2-c) thiazole, leur preparation et les compositions pharmaceutiques qui les contiennent | |
| FR2644456A1 (fr) | Nouveaux derives du 1h, 3h-pyrrolo(1,2-c)thiazolecarboxamide-7, leur preparation et les compositions pharmaceutiques qui les contiennent | |
| EP0114128B1 (de) | 3-Amino-2-oxo-azetidin-Derivate enthaltend in 1-Stellung einen stickstoffhaltigen heterocyclischen Ring, Verfahren zu ihrer Herstellung, ihre Anwendung als Arzneimittel und die Zwischenprodukte zu ihrer Herstellung | |
| FR2662695A1 (fr) | Amino-2 polyfluoroalcoxy-6 benzoselenazoles, leur preparation et les medicaments les contenant. | |
| LU81895A1 (fr) | Nouveaux derives de la perhydrothiazine-1,3, leur preparattion et les medicaments qui les contiennent | |
| LU85556A1 (fr) | Nouveaux derives de l'acide retinoique,leur procede de preparation et compositions medicamenteuse et cosmetique les contenant | |
| CH633010A5 (fr) | Derives de l'isoquinoleine, leur preparation et medicament qui les contient. | |
| FR2528846A1 (fr) | Nouveau derive de la pyrazolo (1,5-a) pyridine, sa preparation et les compositions pharmaceutiques qui le contiennent | |
| EP0772630B1 (de) | Streptograminderivate, ihre herstellung und sie enthaltende pharmazeutische zubereitungen | |
| CA1092120A (fr) | Derives de l'hydroxy-4 thiazolidine thione-2, leur preparation et les compositions qui les contiennent | |
| CH642648A5 (fr) | Derives de l'acide 2-(aminothiazolyl) 2-hydroxyimino acetique. | |
| EP0176444B1 (de) | Verfahren zur Herstellung von 4H-1,2,4-Triazol-Derivaten, so erhaltene neue Triazole, ihre Verwendung als Arzneimittel und sie enthaltende pharmazeutische Zusammensetzungen | |
| WO1979000231A1 (fr) | Nouveaux derives de la thiazoline et leur application comme medicaments | |
| EP0362006A1 (de) | Chinolinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel | |
| FR2537582A1 (fr) | Nouveaux derives de l'ethylene-diamine et de la guanidine | |
| LU81892A1 (fr) | Nouveaux dithiocarbamates, leur preparation et les medicaments qui les contiennent | |
| EP0275221B1 (de) | N-(1H-indol-4-yl)-Benzamidderivate, ihre Salze und deren Anwendung als Heilmittel und Zusammenstellungen, die sie enthalten | |
| CH625249A5 (en) | Process for the preparation of imidazothiazole derivatives | |
| LU84375A1 (fr) | Nouveaux derives de n"-cyano n-oxydo-1 pyridinio-4 guanidine n'-substituee utiles comme medicaments antihypertenseurs et procede de leur preparation | |
| FR2659325A1 (fr) | Nouveaux derives de l'acide 5-phenyl-1h-pyrazole-4-propionique, leur preparation et leur utilisation comme medicaments. | |
| EP0871611B1 (de) | Neue gylcylanilid-derivate, deren herstellung und deren verwendung zur behandlung von hypercholesterolämie und atherosklerose |